Beijing
688068.SSBeijing Hotgen Biotech Co., Ltd. Price (688068.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
88,332,066
(3.8829)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Beijing Hotgen Biotech Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
122.20M
+0% |
142.09M
+16% |
187.12M
+32% |
210.41M
+12% |
513.53M
+144% |
5.37B
+946% |
3.56B
-34% |
541.25M
-85% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 29.28M | 36.83M | 49.13M | 56.55M | 189.95M | 2.17B | 1.65B | 209.84M | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
92.91M
+0% |
105.25M
+13% |
137.99M
+31% |
153.86M
+12% |
323.59M
+110% |
3.20B
+888% |
1.91B
-40% |
331.41M
-83% |
|||||||||||
| Gross Profit Ratio | (0.76%) | (0.74%) | (0.74%) | (0.73%) | (0.63%) | (0.60%) | (0.54%) | (0.61%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 13.29M | 15.63M | 18.38M | 28.99M | 47.61M | 131.92M | 191.14M | 131.45M | |||||||||||
| General and Administrative | 14.87M | 16.99M | 7.61M | 13.44M | 20.08M | 43.61M | 151.51M | 41.23M | |||||||||||
| Selling, General & Admin... | 46.90M | 56.60M | 61.60M | 83.58M | 133.17M | 277.41M | 420.43M | 212.38M | |||||||||||
| Selling & Marketing Exp... | 32.03M | 39.61M | 53.99M | 70.14M | 113.09M | 233.80M | 268.92M | 171.15M | |||||||||||
| Depreciation and Amortiz... | 12.38M | 15.99M | 23.00M | 25.17M | 40.08M | 73.72M | 148.44M | 70.53M | |||||||||||
| Other Expenses | 3.86M | -10,928.80 | -309,739.82 | 3.98M | 23.14M | 115.50M | 59.54M | -29,632,236.00 | |||||||||||
| Total Operating Expenses | 60.87M | 71.22M | 82.74M | 116.55M | 203.92M | 524.83M | 671.10M | 314.20M | |||||||||||
| Cost and Exponses | 90.16M | 108.06M | 131.87M | 173.10M | 393.86M | 2.70B | 2.32B | 524.04M | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
30.08M
+0% |
34.60M
+15% |
55.81M
+61% |
37.37M
-33% |
127.95M
+242% |
2.58B
+1,920% |
1.09B
-58% |
17.21M
-98% |
|||||||||||
| Operating Income Ratio | (0.25%) | (0.24%) | (0.30%) | (0.18%) | (0.25%) | (0.48%) | (0.31%) | (0.03%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 38.29k | 1.40M | 35.60k | 166.14k | 289.93k | 12.50M | 31.12M | 39.59M | |||||||||||
| Interest Expenses | 0.00 | 0.00 | 3.28k | 1.03M | 445.90k | 1.27M | 2.32M | 1.12M | |||||||||||
| Total Other Income/Exp... | 3.86M | -10,929.00 | -309,740.00 | 487.67k | -526,821.00 | -2,607,122.00 | -15,632,619.00 | -3,705,358.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 41.76M | 50.64M | 78.54M | 64.39M | 157.02M | 2.66B | 1.20B | 85.04M | |||||||||||
| EBITDA ratio | (0.36%) | (0.32%) | (0.39%) | (0.30%) | (0.31%) | (0.52%) | (0.39%) | (0.16%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 33.93M | 34.59M | 55.50M | 37.86M | 127.42M | 2.58B | 1.08B | 13.50M | |||||||||||
| Income Before Tax Ratio | (0.28%) | (0.24%) | (0.30%) | (0.18%) | (0.25%) | (0.48%) | (0.30%) | (0.02%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 5.14M | 4.52M | 7.31M | 4.11M | 16.13M | 379.44M | 150.10M | -1,548,890.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 28.80M
+0% |
30.07M
+4% |
48.14M
+60% |
33.88M
-30% |
112.07M
+231% |
2.19B
+1,850% |
944.74M
-57% |
27.38M
-97% |
|||||||||||
| Net Income Ratio | (0.24%) | (0.21%) | (0.26%) | (0.16%) | (0.22%) | (0.41%) | (0.27%) | (0.05%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.44 | 0.43 | 0.70 | 0.37 | 1.22 | 23.75 | 10.55 | 0.31 | |||||||||||
| Diluted EPS | 0.44 | 0.43 | 0.70 | 0.37 | 1.22 | 23.75 | 10.28 | 0.31 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 65.57M | 69.54M | 69.17M | 92.05M | 92.05M | 92.05M | 89.53M | 88.33M | |||||||||||
| Diluted Share Outstanding | 65.57M | 69.54M | 69.17M | 92.05M | 92.05M | 92.05M | 91.90M | 88.33M | |||||||||||